Thrombotic microangiopathy
Clinical trials for Thrombotic microangiopathy explained in plain language.
Never miss a new study
Get alerted when new Thrombotic microangiopathy trials appear
Sign up with your email to follow new studies for Thrombotic microangiopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aimed at saving lives after stem cell transplants
Disease control Recruiting nowThis study tests a drug called iptacopan in 30 people who have a serious blood vessel problem after a stem cell transplant. The drug aims to block a part of the immune system that damages blood vessels. Researchers will check if it helps patients live longer and recover organ fun…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take on tough autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, modified to target and attack faulty immune cells that cause autoimmune diseases. It is for people with severe, hard-to-treat conditions like lupus. The goal is to see if this therapy is safe and can control the…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase 1/2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC